309
Views
19
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: Experience of two pediatric institutions

, , , , , , , , & show all
Pages 1553-1559 | Received 02 May 2008, Accepted 19 May 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rosanna Parasole, Fara Petruzziello, Chiara Messina, Elena Barisone, Andrea Pession, Franco Locatelli, Concetta Micalizzi, Simone Cesaro, Anna Maria Testi, Antonia De Matteo, Stefania Varotto, Massimo Berger, William Morello, Giuseppe Menna & Vincenzo Poggi. (2015) Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study. Leukemia & Lymphoma 56:3, pages 650-655.
Read now
Donato Cosco, Flavio Rocco, Maurizio Ceruti, Margherita Vono, Massimo Fresta & Donatella Paolino. (2012) Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases. International Journal of Nanomedicine 7, pages 2535-2546.
Read now
Deepa Bhojwani & Ching-hon Pui. (2008) Intrathecal liposomal cytarabine: More friend than foe?. Leukemia & Lymphoma 49:8, pages 1427-1430.
Read now

Articles from other publishers (16)

Xuan Chen, Shuting Lu, Fengrong Gong, Xiaoyu Sui, Tingting Liu & Ting Wang. (2022) Research on the synthesis of nanoparticles of betulinic acid and their targeting antitumor activity. Journal of Biomedical Materials Research Part B: Applied Biomaterials 110:8, pages 1789-1795.
Crossref
Shilpa Paul & Nicholas J. Short. (2022) Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management. Current Oncology Reports 24:4, pages 427-436.
Crossref
A Desjonquères, P Chevallier, X Thomas, F Huguet, T Leguay, M Bernard, J-O Bay, E Tavernier, A Charbonnier, F Isnard, M Hunault, P Turlure, M Renaud, J-N Bastié, C Himberlin, S Lepretre, B Lioure, V Lhéritier, V Asnafi, K Beldjord, M Lafage-Pochitaloff, M C Béné, N Ifrah & H Dombret. (2016) Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study. Blood Cancer Journal 6:12, pages e504-e504.
Crossref
Mette Levinsen, Arja Harila-Saari, Kathrine Grell, Olafur Gisli Jonsson, Mervi Taskinen, Jonas Abrahamsson, Kim Vettenranta, Ann Åsberg, Juha Risteli, Jesper Heldrup & Kjeld Schmiegelow. (2016) Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 38:8, pages 602-609.
Crossref
Matthew Trendowski. (2015) Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers. Chemotherapy Research and Practice 2015, pages 1-16.
Crossref
Linfeng Wu, Xiaoxun Li, Dileep R. Janagam & Tao L. Lowe. (2013) Overcoming the Blood-Brain Barrier in Chemotherapy Treatment of Pediatric Brain Tumors. Pharmaceutical Research 31:3, pages 531-540.
Crossref
Jurjen S. Lagas, Bastiaan Nuijen, Jan H. M. Schellens & Jos H. Beijnen. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 689 701 .
N. Gaspar, S. Proust, P. Rachieru, P. Marec-Berard, C. Lervat, D. Orbach & C. Schmitt. (2013) Prise en charge des douleurs associ?es aux m?ningites n?oplasiques en p?diatrie. Revue d'Oncologie H?matologie P?diatrique 1:1, pages 3-14.
Crossref
Franco Locatelli, Martin Schrappe, Maria Ester BernardoSergio Rutella. (2012) How I treat relapsed childhood acute lymphoblastic leukemia. Blood 120:14, pages 2807-2816.
Crossref
Annie Brion, Faezeh Legrand, Fabrice Larosa, Françoise Schillinger, Francine Garnache-Ottou, Philippe Helias, Jean Fontan, Marian Heczko, Philippe Delaby, Etienne Daguindau, Jacqueline Vuillier, Adrien Chauchet & Eric Deconinck. (2011) Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis. Investigational New Drugs 30:4, pages 1697-1702.
Crossref
Alix E. Seif, Anne F. Reilly & Susan R. Rheingold. (2010) Intrathecal Liposomal Cytarabine in Relapsed or Refractory Infant and Pediatric Leukemias: The Children's Hospital of Philadelphia Experience and Review of the Literature. Journal of Pediatric Hematology/Oncology 32:8, pages e349-e352.
Crossref
James E. Jacobs & Caroline Hastings. (2010) Isolated Extramedullary Relapse in Childhood Acute Lymphocytic Leukemia. Current Hematologic Malignancy Reports 5:4, pages 185-191.
Crossref
Michele Spina, Emanuela Chimienti, Ferdinando Martellotta, Emanuela Vaccher, Massimiliano Berretta, Ernesto Zanet, Arben Lleshi, Vincenzo Canzonieri, Pietro Bulian & Umberto Tirelli. (2010) Phase 2 study of intrathecal, long‐acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus‐related non‐Hodgkin lymphoma. Cancer 116:6, pages 1495-1501.
Crossref
Christine Chordas & Kristen Graham. 2010. Pediatric Oncology Nursing. Pediatric Oncology Nursing 203 232 .
Alvaro Lassaletta, Blanca Lopez-Ibor, Elena Mateos, Marta Gonzalez-Vicent, Antonio Perez-Martinez, Julian Sevilla, Miguel A. Diaz & Luis Madero. (2009) Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors. Journal of Neuro-Oncology 95:1, pages 65-69.
Crossref
Ching-Hon Pui & Eckhard Thiel. (2009) Central Nervous System Disease in Hematologic Malignancies: Historical Perspective and Practical Applications. Seminars in Oncology 36, pages S2-S16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.